Back
Eastman Chemical 10K Form
Sell
46
EMN
Eastman Chemical
Last Price:
$90.51
Seasonality Move:
9.1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-26 | 10Q | EMN/Eastman Chemical Quarterly |
2024-02-14 | 10K | EMN/Eastman Chemical Annual |
2023-10-27 | 10Q | EMN/Eastman Chemical Quarterly |
2023-07-28 | 10Q | EMN/Eastman Chemical Quarterly |
2023-04-28 | 10Q | EMN/Eastman Chemical Quarterly |
2023-02-15 | 10K | EMN/Eastman Chemical Annual |
Receive EMN News And Ratings
See the #1 stock for the next 7 days that we like better than EMN
EMN Financial Statistics
Sales & Book Value
Annual Sales: | $9.4B |
---|---|
Cash Flow: | $365M |
Price / Cash Flow: | 15.83 |
Annual Sales: | $50.18 |
Price / Book: | 1.84 |
Profitability
EPS (TTM): | 7.68000 |
---|---|
Net Income (TTM): | $905M |
Gross Margin: | $2.3B |
Return on Equity: | 15.92% |
Return on Assets: | 6.07% |
Eastman Chemical Earnings Forecast
Key Eastman Chemical Financial Ratios
-
The Gross Profit Margin over the past 32 years for EMN is 24.41%.
-
The Selling, General & Administrative Expenses for EMN have been equal to 7.08% of Gross Profit Margin.
-
The Research & Development expenses have been 2.66% of Revenue.
-
The Interest Expense is 23.87% of Operating Income.
-
The Net Earning history of EMN is 9.65% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 17 years.
Eastman Chemical Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Chemicals |
Sector: | Materials |
Current Symbol: | EMN |
CUSIP: | 277432 |
Website: | eastman.com |
Debt
Debt-to-Equity Ratio: | 0.87 |
---|---|
Current Ratio: | 1.51 |
Quick Ratio: | 0.74 |
Price-to-Earnings
Trailing P/E Ratio: | 12.05 |
---|---|
Forward P/E Ratio: | 9.78 |
EMN Technical Analysis vs Fundamental Analysis
Sell
46
Eastman Chemical (EMN)
is a Sell
Is Eastman Chemical a Buy or a Sell?
-
Eastman Chemical stock is rated a SellThe current Eastman Chemical [EMN] share price is $92.41. The Score for EMN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.